Renal fibrosis and proteomics: current knowledge and still key open questions for proteomic investigation

J Proteomics. 2011 Sep 6;74(10):1855-70. doi: 10.1016/j.jprot.2011.05.031. Epub 2011 May 27.

Abstract

Renal tubulo-interstitial fibrosis is a non-specific process, representing the final common pathway for all kidney diseases, irrespective of their initial cause, histological injury, or etiology, leading to gradual expansion of the fibrotic mass which destroys the normal structure of the tissue and results in organ dysfunction and, ultimately, in end-stage organ failure. Proteomic studies of the fibrotic pathophysiological mechanisms have been performed in cell cultures, animal models and human tissues, addressing some of the key issues. This article will review proteomic contribution to the raising current knowledge on renal fibrosis biology and also mention seminal open questions to which proteomic techniques and proteomists could fruitfully contribute.

Publication types

  • Review

MeSH terms

  • Animals
  • Blood Glucose / physiology
  • Cyclosporine / adverse effects
  • Diabetic Nephropathies / complications
  • Diabetic Nephropathies / physiopathology
  • Fibrosis
  • Glomerulonephritis / physiopathology
  • Humans
  • Hypoxia / complications
  • Kidney / pathology*
  • Kidney Diseases / pathology*
  • Kidney Diseases / physiopathology*
  • Kidney Failure, Chronic / physiopathology
  • Proteomics / methods
  • Transforming Growth Factor beta / physiology

Substances

  • Blood Glucose
  • Transforming Growth Factor beta
  • Cyclosporine